Sign in

NCT05457855Completed

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone

Source: ClinicalTrials.gov · Last updated 11 Aug 2025

Brief summary (registry, in English)

This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.

Status (registry)
Completed
Study type
Observational
Enrollment
51533 (actual)
First submitted
11 Jul 2022
Start date
1 Feb 2022
Primary completion date
7 Jul 2023
Lead sponsor
Brigham and Women's Hospital
Diseases
Asthma
NCT number
NCT05457855

What you commit to

  • Study type: Observational
  • Participants enrolled: 51533
  • From 1 Feb 2022 to the primary completion date, 7 Jul 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • 1\. Prior history of dementia measured anytime prior to cohort entry date
  • 2\. Prior history of nursing home admission in the 365 days prior to the cohort entry date

Who the study is looking for

  • 1\. Aged \>/= 65 years on the index date
  • 2\. No prior use of Montelukast and Fluticasone anytime prior to cohort entry date
  • 3\. Enrollment in Medicare Part A, B, and D with no HMO coverage for 365 days prior to and including cohort entry date
  • 4\. At least two claims with asthma diagnosis measured 365 days prior to drug init

Criteria the registry did not label

  • Please see https://docs.google.com/spreadsheets/d/1u8YFpnMHI5HprhyuY14tIgd1COZcsAWKFlbYCT7aL\_A/edit?usp=sharing or Appendix A (https://drive.google.com/file/d/1uC\_G8TJ1ujoJbas1p1gFaYFzY7Hw7xMq/view?usp=sharing) for full code and algorithm definitions.
  • Medicare timeframe: 2008 to 2018 (end of data availability).

Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone (NCT05457855) – Frontlight Research